Your browser doesn't support javascript.
loading
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.
Kemp, John P; Morris, John A; Medina-Gomez, Carolina; Forgetta, Vincenzo; Warrington, Nicole M; Youlten, Scott E; Zheng, Jie; Gregson, Celia L; Grundberg, Elin; Trajanoska, Katerina; Logan, John G; Pollard, Andrea S; Sparkes, Penny C; Ghirardello, Elena J; Allen, Rebecca; Leitch, Victoria D; Butterfield, Natalie C; Komla-Ebri, Davide; Adoum, Anne-Tounsia; Curry, Katharine F; White, Jacqueline K; Kussy, Fiona; Greenlaw, Keelin M; Xu, Changjiang; Harvey, Nicholas C; Cooper, Cyrus; Adams, David J; Greenwood, Celia M T; Maurano, Matthew T; Kaptoge, Stephen; Rivadeneira, Fernando; Tobias, Jonathan H; Croucher, Peter I; Ackert-Bicknell, Cheryl L; Bassett, J H Duncan; Williams, Graham R; Richards, J Brent; Evans, David M.
Afiliação
  • Kemp JP; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.
  • Morris JA; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Medina-Gomez C; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
  • Forgetta V; Department of Human Genetics, McGill University, Montréal, Québec, Canada.
  • Warrington NM; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Youlten SE; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Zheng J; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
  • Gregson CL; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia.
  • Grundberg E; Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.
  • Trajanoska K; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • Logan JG; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Pollard AS; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Sparkes PC; Musculoskeletal Research Unit, Department of Translational Health Sciences, University of Bristol, Bristol, UK.
  • Ghirardello EJ; Department of Human Genetics, McGill University, Montréal, Québec, Canada.
  • Allen R; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Leitch VD; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Butterfield NC; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Komla-Ebri D; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Adoum AT; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Curry KF; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • White JK; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Kussy F; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Greenlaw KM; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Xu C; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Harvey NC; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Cooper C; Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
  • Adams DJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK.
  • Greenwood CMT; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK.
  • Maurano MT; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
  • Kaptoge S; Donnelly Center for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada.
  • Rivadeneira F; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
  • Tobias JH; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Croucher PI; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
  • Ackert-Bicknell CL; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bassett JHD; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Williams GR; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK.
  • Richards JB; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
  • Evans DM; Department of Human Genetics, McGill University, Montréal, Québec, Canada.
Nat Genet ; 49(10): 1468-1475, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28869591
ABSTRACT
Osteoporosis is a common disease diagnosed primarily by measurement of bone mineral density (BMD). We undertook a genome-wide association study (GWAS) in 142,487 individuals from the UK Biobank to identify loci associated with BMD as estimated by quantitative ultrasound of the heel. We identified 307 conditionally independent single-nucleotide polymorphisms (SNPs) that attained genome-wide significance at 203 loci, explaining approximately 12% of the phenotypic variance. These included 153 previously unreported loci, and several rare variants with large effect sizes. To investigate the underlying mechanisms, we undertook (1) bioinformatic, functional genomic annotation and human osteoblast expression studies; (2) gene-function prediction; (3) skeletal phenotyping of 120 knockout mice with deletions of genes adjacent to lead independent SNPs; and (4) analysis of gene expression in mouse osteoblasts, osteocytes and osteoclasts. The results implicate GPC6 as a novel determinant of BMD, and also identify abnormal skeletal phenotypes in knockout mice associated with a further 100 prioritized genes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Calcâneo / Densidade Óssea / Polimorfismo de Nucleotídeo Único / Estudo de Associação Genômica Ampla Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Calcâneo / Densidade Óssea / Polimorfismo de Nucleotídeo Único / Estudo de Associação Genômica Ampla Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article